Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dow Inc (DOW) vs Nuwellis Inc (NUWE) Price & Performance

Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Dow Inc vs Nuwellis Inc — how do they compare? Dow Inc trades at $31.32 (market cap $22.09B), while Nuwellis Inc trades at $1.49 (market cap $522.76K). The key difference: Dow Inc is far larger — about 42256.5× Nuwellis Inc's market cap, and Dow Inc pays a 4.58% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

DOWNUWE
Market Cap
$22.09B$522.76K
Sector
Basic MaterialsTechnology
52-Week High
$41.87$220.50
52-Week Low
$20.65$1.42
Enterprise Value
$37.78B-$1.29M
Dividend Yield
4.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dow Inc

DOW trades at $29.34, down 3.17% today, with technical indicators showing bearish momentum. The company faces fundamental challenges with negative net income margin of -3.13% and declining revenue from $56.9B in 2022 to $40.0B in 2025. Recent earnings beats provide some optimism, but cash flow from operations has weakened significantly from $7.5B in 2022 to $1.0B in 2025. The stock trades near the lower end of analyst price targets with consensus at $35.11.

DOW presents a mixed investment case with valuation metrics showing potential undervaluation (P/S 0.51) offset by profitability concerns. The chemical sector faces cyclical pressures, but recent dividend payments and earnings beats suggest operational resilience. Key risks include continued revenue decline and high debt levels approaching 30% of assets. Analyst sentiment remains cautious with only 33% buy ratings.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

About Dow Inc

Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.

Read more on DOW

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE